BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

375 related articles for article (PubMed ID: 25468806)

  • 1. Increased plasma concentrations of midregional proatrial natriuretic Peptide is associated with risk of cardiorenal dysfunction in type 1 diabetes.
    Theilade S; Hansen TW; Goetze JP; Rossing P
    Am J Hypertens; 2015 Jun; 28(6):772-9. PubMed ID: 25468806
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Central hemodynamics are associated with cardiovascular disease and albuminuria in type 1 diabetes.
    Theilade S; Hansen TW; Rossing P
    Am J Hypertens; 2014 Sep; 27(9):1152-9. PubMed ID: 24627444
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Soluble urokinase plasminogen activator receptor levels are elevated and associated with complications in patients with type 1 diabetes.
    Theilade S; Lyngbaek S; Hansen TW; Eugen-Olsen J; Fenger M; Rossing P; Jeppesen JL
    J Intern Med; 2015 Mar; 277(3):362-371. PubMed ID: 24830873
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of midregional pro-atrial natriuretic peptide with N-terminal pro-B-type natriuretic peptide in predicting survival in patients with chronic heart failure.
    von Haehling S; Jankowska EA; Morgenthaler NG; Vassanelli C; Zanolla L; Rozentryt P; Filippatos GS; Doehner W; Koehler F; Papassotiriou J; Kremastinos DT; Banasiak W; Struck J; Ponikowski P; Bergmann A; Anker SD
    J Am Coll Cardiol; 2007 Nov; 50(20):1973-80. PubMed ID: 17996563
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relation of plasma midregional proatrial natriuretic peptide to target organ damage in adults with systemic hypertension.
    Khaleghi M; Al-Omari MA; Kondragunta V; Morgenthaler NG; Struck J; Bergmann A; Mosley TH; Kullo IJ
    Am J Cardiol; 2009 May; 103(9):1255-60. PubMed ID: 19406268
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of Natriuretic Peptides as Risk Markers for All-Cause Mortality and Cardiovascular and Renal Complications in Individuals With Type 1 Diabetes.
    Tofte N; Theilade S; Winther SA; Birkelund S; Goetze JP; Hansen TW; Rossing P
    Diabetes Care; 2021 Feb; 44(2):595-603. PubMed ID: 33323477
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MR-proANP improves prediction of mortality and cardiovascular events in patients with STEMI.
    Lindberg S; Jensen JS; Pedersen SH; Galatius S; Goetze JP; Mogelvang R
    Eur J Prev Cardiol; 2015 Jun; 22(6):693-700. PubMed ID: 24906365
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Midregional proatrial natriuretic peptide predicts survival in exacerbations of COPD.
    Bernasconi M; Tamm M; Bingisser R; Miedinger D; Leuppi J; Müller B; Christ-Crain M; Stolz D
    Chest; 2011 Jul; 140(1):91-99. PubMed ID: 21106656
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma N-terminal B-Type natriuretic peptide as an indicator of long-term survival after acute myocardial infarction: comparison with plasma midregional pro-atrial natriuretic peptide: the LAMP (Leicester Acute Myocardial Infarction Peptide) study.
    Khan SQ; Dhillon O; Kelly D; Squire IB; Struck J; Quinn P; Morgenthaler NG; Bergmann A; Davies JE; Ng LL
    J Am Coll Cardiol; 2008 May; 51(19):1857-64. PubMed ID: 18466800
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma high-sensitivity troponin T predicts end-stage renal disease and cardiovascular and all-cause mortality in patients with type 1 diabetes and diabetic nephropathy.
    Galsgaard J; Persson F; Hansen TW; Jorsal A; Tarnow L; Parving HH; Rossing P
    Kidney Int; 2017 Nov; 92(5):1242-1248. PubMed ID: 28712855
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of midregional pro-atrial and B-type natriuretic peptides in chronic heart failure: influencing factors, detection of left ventricular systolic dysfunction, and prediction of death.
    Moertl D; Berger R; Struck J; Gleiss A; Hammer A; Morgenthaler NG; Bergmann A; Huelsmann M; Pacher R
    J Am Coll Cardiol; 2009 May; 53(19):1783-90. PubMed ID: 19422985
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pulse wave reflection is associated with diabetes duration, albuminuria and cardiovascular disease in type 1 diabetes.
    Theilade S; Lajer M; Hansen TW; Rossing P
    Acta Diabetol; 2014 Dec; 51(6):973-80. PubMed ID: 25274394
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Associations of Proatrial Natriuretic Peptide with Components of the Metabolic Syndrome in Adolescents and Young Adults from the General Population.
    Goharian TS; Goetze JP; Faber J; Andersen LB; Grøntved A; Jeppesen JL
    Am J Hypertens; 2017 Jun; 30(6):561-568. PubMed ID: 28338810
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The combined contribution of albuminuria and glomerular filtration rate to the prediction of cardiovascular mortality in elderly men.
    Nerpin E; Ingelsson E; Risérus U; Sundström J; Larsson A; Jobs E; Jobs M; Hallan S; Zethelius B; Berglund L; Basu S; Arnlöv J
    Nephrol Dial Transplant; 2011 Sep; 26(9):2820-7. PubMed ID: 21335440
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasma natriuretic peptides and incidence of subtypes of ischemic stroke.
    Berntsson J; Zia E; Borné Y; Melander O; Hedblad B; Engström G
    Cerebrovasc Dis; 2014; 37(6):444-50. PubMed ID: 25060145
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Midregional-proAtrial Natriuretic Peptide and High Sensitive Troponin T Strongly Predict Adverse Outcome in Patients Undergoing Percutaneous Repair of Mitral Valve Regurgitation.
    Wöhrle J; Karakas M; Trepte U; Seeger J; Gonska B; Koenig W; Rottbauer W
    PLoS One; 2015; 10(9):e0137464. PubMed ID: 26368980
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The prognostic value of midregional proatrial natriuretic peptide in patients with hemorrhagic stroke.
    Fischer M; Katan M; Morgenthaler NG; Seiler M; Müller B; Lackner P; Errath M; Helbok R; Pfausler B; Beer R; Schmutzhard E; Broessner G
    Cerebrovasc Dis; 2014; 37(2):128-33. PubMed ID: 24481415
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intensive Lifestyle Intervention Increases Plasma Midregional Proatrial Natriuretic Peptide Concentrations in Overweight Children.
    Thomsen CF; Goharian TS; Larsen KT; Goetze JP; Andersen LB; Jeppesen JL
    J Am Heart Assoc; 2021 Jul; 10(13):e020676. PubMed ID: 34180245
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Determinants of N-terminal proatrial natriuretic peptide plasma levels in a survey of adult male population from Southern Italy.
    Rubattu S; Barbato A; Marchitti S; Iacone R; Di Castro S; Evangelista A; Stanzione R; Ippolito R; Sciarretta S; Palmieri L; Volpe M; Strazzullo P;
    J Hypertens; 2010 Aug; 28(8):1638-45. PubMed ID: 20453667
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Galectin 3: association to neurohumoral activity, echocardiographic parameters and renal function in outpatients with heart failure.
    Stoltze Gaborit F; Bosselmann H; Kistorp C; Iversen K; Kumler T; Gustafsson F; Goetze JP; Sölétormos G; Tønder N; Schou M
    BMC Cardiovasc Disord; 2016 May; 16():117. PubMed ID: 27246703
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.